X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
male (66) 66
female (64) 64
cardiac & cardiovascular systems (62) 62
middle aged (54) 54
index medicus (53) 53
aged (50) 50
mortality (31) 31
treatment outcome (27) 27
cardiology (26) 26
cardiovascular (26) 26
risk factors (26) 26
abridged index medicus (25) 25
cardiac patients (24) 24
heart attacks (24) 24
cardiovascular disease (22) 22
follow-up studies (22) 22
heart attack (21) 21
france - epidemiology (18) 18
registries (18) 18
acute coronary syndromes (17) 17
prospective studies (17) 17
coronary disease - therapy (16) 16
coronary heart disease (16) 16
coronary artery disease (15) 15
myocardial infarction (15) 15
transluminal angioplasty (15) 15
internal medicine (14) 14
life sciences (14) 14
prognosis (14) 14
time factors (14) 14
aged, 80 and over (13) 13
cardiology and cardiovascular medicine (13) 13
coronary vessels (13) 13
myocardial infarction - mortality (13) 13
patients (13) 13
percutaneous coronary intervention (13) 13
analysis (12) 12
association (12) 12
drug therapy (12) 12
france (12) 12
medical research (12) 12
myocardial infarction - therapy (12) 12
risk (12) 12
studies (12) 12
therapy (12) 12
angina pectoris (11) 11
angioplasty, balloon, coronary (11) 11
cardiovascular diseases (11) 11
care and treatment (11) 11
coronary angiography (11) 11
electrocardiography (11) 11
myocardial-infarction (11) 11
adult (10) 10
clinical medicine (10) 10
clinical trials (10) 10
disease (10) 10
ischemia (10) 10
management (10) 10
medicine, experimental (10) 10
patient outcomes (10) 10
platelet aggregation inhibitors - therapeutic use (10) 10
acute myocardial infarction (9) 9
acute myocardial-infarction (9) 9
coronary artery bypass (9) 9
double-blind method (9) 9
health aspects (9) 9
intervention (9) 9
medical and health sciences (9) 9
medical imaging (9) 9
medicin och hälsovetenskap (9) 9
medicine, general & internal (9) 9
outcomes (9) 9
stroke (9) 9
angioplasty (8) 8
epidemiology (8) 8
klinisk medicin (8) 8
recurrence (8) 8
reperfusion (8) 8
trial (8) 8
aspirin (7) 7
cardiovascular system (7) 7
coronary disease - physiopathology (7) 7
diagnosis (7) 7
follow-up (7) 7
guidelines (7) 7
heart (7) 7
heart diseases (7) 7
heart failure (7) 7
hospital mortality (7) 7
incidence (7) 7
multivariate analysis (7) 7
myocardial infarction - drug therapy (7) 7
myocardial infarction - epidemiology (7) 7
prevention (7) 7
proportional hazards models (7) 7
registry (7) 7
research (7) 7
survival rate (7) 7
survival rate - trends (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 50, Issue 9, pp. 823 - 830
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9670, pp. 1190 - 1197
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 113, Issue 2, pp. 355 - 360
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 22, pp. 2710 - 2720
Abstract Background For acute myocardial infarction (AMI) without heart failure (HF), it is unclear if β-blockers are associated with reduced mortality.... 
Cardiovascular | Internal Medicine | NSTEMI | preserved left ventricular systolic function | STEMI | average treatment effect | survival | propensity score | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | METOPROLOL | TRIAL | THERAPY | DISEASE | OUTCOMES | Heart Failure - complications | Myocardial Infarction - mortality | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Ventricular Dysfunction - complications | Humans | Middle Aged | Ventricular Dysfunction - drug therapy | Male | Heart Failure - drug therapy | Dose-Response Relationship, Drug | Hospital Mortality - trends | Myocardial Infarction - complications | Propensity Score | Myocardial Infarction - drug therapy | Electrocardiography | Female | Registries | Aged | United Kingdom - epidemiology | Adrenergic beta-Antagonists - administration & dosage | Myocardial infarction | Heart attacks | Adjustment | Syngeneic grafts | Mortality | Cardiovascular disease | Coefficients | Patients | Survival | Beta blockers | Elevation | Weighting | Ischemia | Risk assessment | Xenografts | Death | Fatalities | Infarction | Ventricle | Health risk assessment | Drug therapy | Heart diseases | PCI, percutaneous coronary intervention | CI, confidence interval | AMI, acute myocardial infarction | ATE, average treatment effect | STEMI, ST-segment elevation myocardial infarction | MINAP, Myocardial Ischaemia National Audit Project | LVSD, left ventricular systolic dysfunction | NSTEMI, non–ST-segment elevation myocardial infarction | HF, heart failure | Original Investigation | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2017, Volume 130, Issue 5, pp. 555 - 563
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 117, Issue 1, pp. 17 - 21
Journal Article
Journal Article
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 119, Issue 5, pp. 692 - 697
Abstract The prognosis of patients with acute myocardial infarction (AMI) has notably improved in the past 20 years. Using the FAST-MI (French Registry of... 
Cardiovascular | ST-ELEVATION | TRIAL | MORTALITY | POPULATION | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR EVENTS | STATIN THERAPY | HEART-FAILURE | RISK | ACUTE CORONARY SYNDROMES | ELEVATION MYOCARDIAL-INFARCTION | Multivariate Analysis | Myocardial Infarction - epidemiology | Age Distribution | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Atherosclerosis - epidemiology | Case-Control Studies | Cause of Death | Myocardial Infarction - therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aged, 80 and over | Female | Registries | Cerebrovascular Disorders - epidemiology | France | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Mortality | Risk Factors | Proportional Hazards Models | Treatment Outcome | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Artery Bypass | Aged | Coronary Artery Disease - epidemiology | Angiotensin Receptor Antagonists - therapeutic use | Longitudinal Studies | Percutaneous Coronary Intervention | Cardiology | Patient outcomes | Cardiac patients | Heart attack | Medicine, Experimental | Medical research | Intervention | Heart failure | Enzymes | Stroke | Heart attacks | Cardiovascular disease | Angina pectoris | Multivariate analysis | Clinical outcomes | Variables | Coronary vessels | Population | Acute coronary syndromes | Statins | Angiotensin Receptor Antagonists | Adrenergic beta-Antagonists | Life Sciences | Angiotensin-Converting Enzyme Inhibitors | Atherosclerosis | Hydroxymethylglutaryl-CoA Reductase Inhibitors | Cardiology and cardiovascular system | Cerebrovascular Disorders | Coronary Artery Disease | Human health and pathology | Myocardial Infarction | Platelet Aggregation Inhibitors
Journal Article
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 114, Issue 11, pp. 1651 - 1657
Journal Article